Broadcasting News

Lee Soo-young Temporarily Steps Down from Radio Show as Her Son Battles Leukemia… “I Need to Be by His Side as a Mother”

On the radio station’s official website bulletin board "I Can't Take My Eyes Off My Child as Intensive Cancer Treatment Continues," She Revealed

JOO MEE_HEE
2026-10-05 18:04:27
[Edaily Starin JOO MEE_HEE Reporter] Singer Lee Soo-young is temporarily stepping away from her radio DJ position—a role she has held for nearly nine years—to devote herself to her child’s leukemia treatment.
Lee Soo-young. (Photo courtesy of New Era Project/Yonhap News)

On the 5th, Lee Soo-young announced on the official website bulletin board of CBS Music FM’s “Let’s Meet at 12:00 with Lee Soo-young” that her child is battling an illness and that she will be suspending her hosting duties for the time being.
Lee Soo-young said, “Before the Chuseok holiday, my child suddenly fell ill and was diagnosed with ‘acute T-cell lymphoblastic leukemia’ during a hospital examination, leading to hospitalization,” adding, “Treatment has now begun, and my child is holding up well.”
As the treatment is expected to be lengthy, she has decided to stay by her child’s side for the time being. She explained, “The expected treatment period is long, and since the initial phase involves intensive chemotherapy, I cannot take my eyes off my child for even a moment.”
She continued, “As a mother, I believe this is the time I must be there to support my child through this difficult treatment process—it was a difficult decision to make,” adding, “I would be grateful if you could pray for my child. I look forward to the day when I can greet you all again in good health.”
Lee Soo-young has been the DJ of “Let’s Meet at 12” since 2017, connecting with listeners for about nine years. She has decided to step away from the microphone temporarily to focus on her child’s treatment.

Economy

Corporation

IT·Science

Economy

Japanese Finance Minister Proposes "Combination of Stablecoins, Tokenized Deposits, and Government Bonds"... to Lead a Government-Wide Forum

As the Japanese government moves forward with plans to incorporate crypto assets into the framework of the Financial Instruments and Exchange Act (hereinafter referred to as the FIEA), the government …
2026-11-20 14:30:21

Corporation

curacle co., ltd. Files for U.S. Phase 2b Clinical Trial of CU06, an Oral Treatment for Diabetic Macular Edema

curacle co., ltd.(365270)is moving forward with a U.S. Phase 2b clinical trial to develop an oral treatment for diabetic macular edema (DME). The trial will re-evaluate the treatment’s efficacy in pat…
2026-11-20 13:02:02

IT·Science

Aimed Bio Inc.’s ADC Technology Export Shows 60% Response Rate in Phase 1 Clinical Trial… Moving Forward with U.S. Approval Trials

#Aimed Bio Inc.’s antibody-drug conjugate (ADC) “BHV-1530 (AMB302),” which was licensed to U.S.-based Biohaven, has demonstrated initial anticancer efficacy in a Phase 1 clinical trial. Biohaven plans…
2026-11-20 13:07:02